|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘 | Becker MA Schumacher HR Jr Wortman RL | 2005 | N Engl J Med2005，353，23： | 1 |
| 2 | MicroRNAs in NF-kappa B signaling 显示文摘 | Ma X Becker Buscaglia LE Barker JR | 2011 | J Mol Cell Biol2011，3，3： | 1 |
| 3 | Febuxostatin the treatment of gout: 5-yr findings of the FOCUS efficacyand safety study 显示文摘 | Schumacher HR Jr Becker MA Lloyd E | 2009 | Rheumatology (Oxford)2009，48，2： | 1 |
| 4 | Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study显示文摘 | Schumacher HR Jr Becker MA Lloyd E | 2009 | Rheumatology2009，48，2： | 1 |
| 5 | Effects of fe-buxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout:a28-week,phaseⅢ,ran-domized,double-blind,parallel-group trial显示文摘 | Schumacher HR Jr Becker MA Wortmann RL | 2008 | Arthritis Rheum2008，59，11： | 1 |
| 6 | Micro RNAs in NF-kappa B signaling显示文摘 | Ma X Becker Buscaglia LE Barker JR | 2011 | J Mol Cell Biol2011，3，： | 1 |
| 7 | Changes in cognitive functioning following treatment of late-life depression 显示文摘 | Butters MA Becker Jr Nebes RD | 2000 | Am J Psychiatry2000，157，12： | 1 |
| 8 | A phase 3 randomized, controlled, multicenter, double-blind trial (RCT) comparing efficacy and safety of daily febuxostat (FEB) and allopurinol (ALLO) in subjects with gout 显示文摘 | Becker MA Schumacher HR Jr Espinoza L | 2008 | Arthritis Rheum2008，58，9： | 1 |
| 9 | Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study显示文摘 | SCHUMACHER HR Jr BECKER MA LLOYD E | 2009 | Rheumatology (Oxford)2009，48，2： | 1 |
| 10 | Magnetic resonance imaging in the quantitative assessment of gouty tophi显示文摘 | Schumacher HR Jr Becker MA Edwards NL | | 0，，： | 1 |
| 11 | Febuxostat, a novel nonpurine selective inhibitor of xanthine oxi- dase: A twenty-eightday, multicenter, phase II, randomized, double-blind, placebocontrolled, dose-response clinical trial ex- amining safety and efficacy in patients with gout 显示文摘 | BECKER MA SCHUMACHER HR JR WORTMANN RL | 2005 | Arthritis Rheum2005，52，3： | 1 |
| 12 | Febuxostat compared with allopurinol in patients with hyperurice- mia and gout 显示文摘 | BECKER MA SCHUMACHER HR JR WORTMANN RL | 2005 | N Engl J Med2005，353，23： | 1 |
| 13 | Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperurieemia and gout : a 28-week, phase III, randomized, double-blind, parallel-group trial显示文摘 | SCHUMACHER HR JR BECKER MA WORTMANN RL | 2008 | Ar- thritis Rheum2008，59，11： | 1 |
| 14 | Fe-buxostat in the treatment of gout: 5-Yr findings of the FOCUS ef- ficacy and safety study 显示文摘 | SCHUMACHER HR JR BECKER MA LLOYD E | 2009 | Rheumatology2009，48，2： | 1 |
| 15 | MicroRNAs in NF-kappaB signaling 显示文摘 | Ma X Becker Buscaglia LE Barker JR | 2011 | J Mol Cell Biol2011，3，： | 1 |
| 16 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘 | Becker MA Schumacher HR Jr Wortmann RL | 2005 | N EnglJ Med2005，353，23： | 1 |
| 17 | MicroRNAs in NF-kappaB signaling显示文摘 | Ma X Becker Buscaglia IrE Barker JR | 2011 | J Mol Cell Biol2011，3，3： | 1 |
| 18 | Mag- netic resonance imaging in the quantitative assessment of gouty tophi 显示文摘 | Schumacher HR Jr Becker MA Edwards NL | 2006 | Int J Clin Pract2006，60，4： | 1 |
| 19 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘 | Becker MA Schumacher HR Jr Wortmann RL | 2005 | N Engl J Med2005，353，： | 1 |
| 20 | Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout:a 28-week,phase III,randomized,double-blind,parallel-group trial显示文摘 | Schumacher HR Jr Becker MA Wortmann RL | 2008 | Arthritis Rheum2008，59，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员